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DIALYSIS – TRANSPLANTATION
Magnetic resonance imaging detection of rat renal transplant
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Magnetic resonance imaging detection of rat renal transplant (that is, over a 70% 5-year survival rate with kidney trans-
rejection by monitoring macrophage infiltration. plantation from living-related donors), a superior quality
Background. A rat renal transplantation model was studied
of life (as compared with hemodialysis or peritoneal dial-by noninvasive magnetic resonance imaging (MRI) with an
ysis), and improved rehabilitation. For a review of kidneyinfusion of ultrasmall superparamagnetic iron oxide (USPIO)
particles to test whether the accumulation of immune cells, transplantation, refer to Racusen, Solez, and Burdick [2].
such as macrophages, could be detected in vivo while the kidney Long-term survival is still threatened by repeated epi-
transplant was being rejected.
sodes of acute rejection and by chronic rejection. ThroughMethods. Major histocompatibility disparate DA to BN male
renal biopsies, it has been found that as many as 30%rat renal transplantation recipients were infused with USPIO
particles, with magnetic resonance (MR) images acquired be- of all renal transplantation cases develop rejection within
fore, immediately after, and one day following infusion. one year, even with the intervention of various immuno-
Results. When the USPIO infusion was on the fourth day
suppressive regimens. Other potential complications ofpost-transplantation, some rejecting allografts showed a de-
renal transplants include infection caused by immuno-crease of MR signal intensity one day later. Isografts and allo-
grafts with triple immunosuppressant treatment had no MR suppression, nephrotoxicity, etc. [3]. Clinically, chronic
signal reduction. Immunohistologic staining for ED11 macro- rejection of renal transplants, like most other solid organ
phages and CD41 and CD81 T cells in allogeneic transplanted
transplants, is the leading cause of late allograft failure.kidneys indicated the accumulation of these immune cells as
Although the pathophysiological mechanism of chronicacute rejection occurred. Morphological studies by electron
microscopy confirmed the existence of iron inside the lyso- rejection remains poorly understood, frequent episodes
somes of macrophages of rejecting kidneys, while Prussian blue of acute rejection are known to be highly associated with
staining detected the presence of iron plaques in macrophages.
the development of this irreversible process [4]. As theIsografts and allografts with a triple immunosuppressant treat-
occurrence of acute rejection episodes often is the mostment exhibited smaller MR signal reductions with minimal
histologic changes. predictive factor for the later development of chronic
Conclusions. The concurrence of MR signal reduction fol- rejection in adults [5] and children [6], many clinicians
lowing USPIO infusion with pathological manifestation in a
advocate strategies to detect and ablate acute rejectionrat renal allograft model suggests the possibility that renal
episodes as early as possible. Although histologic evalua-transplantation status may be assessed by MRI using USPIO
particles as markers for the accumulation of immune cells, such tion from renal biopsy is generally accepted as the “gold
as macrophages. standard” for diagnosing graft rejection, the biopsy pro-
cedure exposes the patient to the risk of possible bleed-
ing, kidney rupture, infection, and arterial venous fistula,
Renal transplantation is a commonly preferred surgi- potentially even causing the loss of the graft [2, 7]. Thus,
cal procedure for patients with end-stage nonmalignant there is an urgent need to develop reliable organ- and/or
renal disease [1, 2]. It is now recognized to be the most cell-specific, noninvasive techniques for in vivo detection
effective treatment because it offers the best prognosis of organ rejection.
T-cell recognition of allo-antigen releases signals that
trigger T-cell activation, and the subsequent infiltrationKey words: immune cells, T cell, ultrasmall superparamagnetic iron
oxide, kidney transplantation, acute rejection. of activated CD41 and CD81 T cells, macrophages, and
natural killer cells into the graft are key events of acute
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influence initial and late changes and may be more im- intravenous injection of puromycin aminonucleoside
[21]. In the present study, detection of immune cell accu-portant in the process than hitherto appreciated [9–11].
mulation was tested in rats with transplanted kidneys bySince T cells and macrophages accumulate at the site
measuring the MRI signal intensity of the transplantedof inflammation, thus leading to graft rejection, we are
kidneys following infusion of USPIO particles by stain-developing noninvasive methods to monitor the presence
ing with immunohistologic markers and by staining withand accumulation of these immune cells in vivo by mag-
iron markers.netic resonance imaging (MRI) techniques. The aim of
the present study was to investigate the feasibility of using
MRI to detect the accumulation of immune cells con- METHODS
taining ingested ultrasmall superparamagnetic iron oxide
In vitro MR and TEM assessment of the uptake of(USPIO; it should be noted that in our previous publica-
USPIO particles by macrophagestions [12–14], we used the terminology “SPIO” for parti-
Uptake of USPIO particles by macrophages was as-cles of size similar to those used in the present study,
sessed in vitro by exposing a macrophage cell populationnamely approximately 30 nm. However, in this article,
to USPIO particles, followed by MRI and transmissionwe refer to them as “USPIO,” consistent with the termi-
electron microscopy (TEM) investigations. Macrophagesnology used by other groups [15–20] to differentiate them
were isolated from the spleens of BN rats according tofrom the larger iron oxide particles, which exhibit differ-
published methods [22] and were cultured in reconstitu-ent biodistribution properties.) particles in vivo in reject-
ted RPMI 1640 culture medium (GIBCO, Grand Island,ing transplanted kidney of a rat, with the view of developing
NY, USA) under 5% CO2 at 378C. The cells were thena new noninvasive way to detect early stages of graft rejec-
incubated with USPIO (2 mg Fe/10 3 106 cells) for 20tion. Superparamagnetic iron oxide (SPIO) and USPIO
hours and recovered with three washes of phosphate-particles reduce the MR signal intensity of water because
buffered saline (PBS).of the magnetic susceptibility effect produced by iron
High-resolution gradient-echo MR images of labeledand are excellent MR contrast agents [15]. Large SPIO
and unlabeled macrophage cell phantoms (containingparticles (for example, AMI-25 with mean diameter
2 3 106 and 0.5 3 106 cells/mL) were obtained using a<150 nm), which have been used as MRI contrast agents
7-T, 15 cm horizontal bore Bruker AVANCE DRX MRfor detecting liver cancer and spleen tumors [16, 17],
instrument equipped with a 4.3 cm microimaging gradi-
accumulate in cells of the mononuclear phagocytic sys-
ent set. Acquisition parameters were TR/TE 5 1000/30
tem (MPS) of liver and spleen and are cleared from ms; flip angle 5 458; matrix size 5 256 3 256, giving an
the blood within minutes. Smaller SPIO particles (for in-plane resolution of 50 3 50 mm; slice thickness 5
example, AMI-227, USPIO with mean diameter <20 nm) 100 mm; acquisition bandwidth 5 25 kHz; number of
have an intravascular distribution, migrate very slowly averages 5 4; and scan time 5 17 minutes.
across the capillary endothelium, have a longer half-life Transmission electron microscopy was performed to
of about two hours in blood [18–20], are not immediately characterize further the location of USPIO particles in
recognized by the MPS of liver and spleen, and are ame- the macrophages. The MRI and TEM studies on macro-
nable to uptake by macrophages in more widespread phages followed the procedures described earlier for the
areas of tissue. They can be eliminated without glomeru- characterization of USPIO-labeled T cells [14].
lar filtration by the organs of the MPS [19]. The slow
elimination of these small particles allows the observa- Animals
tion of signal modification in the vascular space. Inbred DA (RT1a) and BN (RT1n) male rats (200 to
There are two potential approaches for labeling im- 250 g) were purchased from Harlan-Sprague Dawley
mune cells that accumulate in the graft rejection process. (Indianapolis, IN, USA) and were housed in the animal
First, the cells can be labeled ex vivo by a suitable MRI facility of the Pittsburgh NMR Center for Biomedical
contrast agent, such as dextran-coated USPIO particles Research (Carnegie Mellon University, Pittsburgh, PA,
[12], and then the labeled cells can be infused into an USA). Animal care and experimentation were in compli-
animal as we have done to track the migration of USPIO- ance with the principles described in the Principles of
labeled T cells to the site of an inflammation created by Laboratory Animal Care and Guide for the Use of Labo-
the injection of calcium ionophore (A23187) into a rat ratory Animals, published by the National Institutes of
testicle [13]. Second, USPIO particles can be infused Health (NIH Publication no. 96-03, revised 1996). The
intravenously into an animal in the hope of detecting present study was approved by the Institutional Animal
the accumulation of USPIO-containing immune cells at Care and Use Committee of Carnegie Mellon University.
the rejecting graft. This second approach is based on the
Renal transplantationrecent finding of the detection of macrophage infiltration
of the kidney by MRI after injection of USPIO particles Transplantation was performed on male rats approxi-
mately 8 to 10 weeks old, weighing 250 to 300 g. BN ratsin a rat model of experimental nephropathy caused by
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were used as recipients throughout and as donors for filter sterilized, and assayed for iron content [25]. The
solution was diluted with PBS to a concentration of 9syngeneic transplantation (isografts), while DA rats served
as donors for allogeneic transplantation (allografts). The mmol Fe/mL, and 0.5 mL of the suspension was injected
intravenously for each study.animals were anesthetized by inhalation of methoxyflu-
rane (Mallinckrodt Veterinary, Mundelein, IL, USA).
In vivo MRI studies of renal transplantationThe left nephrectomy of the recipient was performed
before the left kidney transplantation. The graft (the In vivo studies of the effect of USPIO particle infusion
on transplanted kidneys were performed on a 4.7-T, 40donor left kidney) was flushed with University of Wis-
consin solution (DuPont Pharma, Wilmington, DE, USA) cm horizontal bore Bruker AVANCE DRX MR instru-
ment. The rats were under general anesthesia with endo-containing heparin and then stored in the same solution
at 48C. The ischemia time was 15 to 20 minutes. Follow- tracheal intubation (O2 70%, N2O 30%, and 1.5%
isoflurane) during the MR experiments. A 20 cm PE50ing the microsurgical technique of Lee, the donor renal
artery and vein were anastomosed end to side to the catheter was inserted into the left jugular vein for the
infusion of USPIO particles. Coronal MR images of bi-recipient abdominal aorta and inferior vena cava with
10-0 sutures (Prolene; ETHICON, Somerville, NJ, USA) lateral kidneys were obtained before, immediately after,
and 22 to 24 hours following infusion of USPIO particles.[23]. The ureter of the recipient was anastomosed end
to end with the donor’s ureter by 11-0 sutures (Ethilon; Gradient-echo images were triggered to respiratory mo-
tion with: TR/TE 5 1000/12 ms; flip angle 5 Ernst angle;ETHICON) using four stitches. The right kidney was
kept intact as an internal control for each individual rat slice thickness 5 1 mm; 15 contiguous slices; field of
view 5 7.0 cm; data matrix size 5 256 3 130 (zero-filledtransplantation. Thirty-four transplantations were per-
formed for our studies in six groups. Transplants were to 256 3 256); two averages; and scan time 5 4.3 minutes.
Field homogeneity was optimized by shimming on a sliceexamined by MRI before, immediately after, and one
day after infusion of USPIO particles. Syngeneic trans- centered on both kidneys.
The average changes of MR signal intensity were mea-plants were infused with USPIO particles at postopera-
tive day (POD) 4 (N 5 6). Allogeneic transplants were sured in two different compartments, cortex and me-
dulla, both in transplanted and native kidneys. Regionsinfused at POD 2 (N 5 3), POD 4 (N 5 12), and POD 6
(N 5 3), and allogeneic transplants were infused with a of interests (ROIs) for cortex and medulla were traced
by hand (using the Bruker image processing software)triple immunosuppressive treatment at POD 4 (N 5 5).
The triple immunosuppressive treatment consisted of daily on the center slice of each kidney (or as close as possible).
Regions were defined on the MR images acquired imme-subcutaneous injections of methylprednisolone (2 mg/kg;
Pharmacia, Kalamazoo, MI, USA), rapamycin (1 mg/kg; diately after the infusion of the USPIO particles, which
showed the best corticomedullary differentiation; theseSigma, St. Louis, MO, USA), and cyclosporine A (CsA,
5 mg/kg; Sandoz, East Hanover, NJ, USA) on POD 1 ROIs were also used to analyze the preinfusion images.
ROIs for the images acquired one day later were drawnthrough POD 4. One group of allograft recipients (N 5
5) was sacrificed at POD 1 without USPIO infusion to to be as close as possible to the initial ROIs. A typical
ROI drawn for the cortex was comprised of 150 pixelsserve as a baseline for evaluating the cellular kinetics.
(volume of approximately 11 mm3) and for the medulla
Preparation and infusion of USPIO particles of 500 to 600 pixels (volume of approximately 37 to
45 mm3). MR signal intensity was normalized to that ofA stock suspension of dextran-coated USPIO particles
was synthesized in our laboratory according to Palmacci muscle of the same rat, as the muscle tissue was known
not to readily take up iron [21]. The signal intensityand Josephson [24] with slight modifications. The initial
iron content in the particle suspension was determined reduction in each animal was calculated according to:
for all samples using a spectrophotometric method [25].
100 · (Ipre 2 Ipost)/Ipre (Eq. 1)Iron-core size, mean diameter of whole particles, and
MR relaxation measurements of USPIO particles were where Ipre is the signal intensity before USPIO infusion,
and Ipost is the signal intensity after USPIO infusion, withcarried out as described in Dodd et al [14]. Iron-core
size measured by TEM was found to be in the range 4.0 both first normalized to the muscle signal intensity.
to 7.5 nm. Mean diameter of whole particles measured
Histology, immunohistochemistry, and iron stainingby laser light scattering was 29 6 3 nm. The MR relaxivi-
for USPIO detectionties, R1 (spin-lattice relaxation rate constant, 1/T1, per
mole of Fe in USPIO) and R2 (spin-spin relaxation rate Rats were sacrificed for histologic evaluations at one
day after USPIO infusion following the MRI studies.constant, 1/T2, per mole of Fe in USPIO), at 4.7 T were
3.8 3 104 and 9.1 3 104 mol/L21 s21, respectively. Before each animal was sacrificed, 0.5 mL of blood was
sampled for analysis of serum creatinine content. ThePrior to infusion of USPIO particles for in vivo studies,
a portion of the stock suspension was dialyzed in PBS, harvested graft and native kidneys were fixed in 3.7%
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Fig. 1. Gradient-echo magnetic resonance
(MR) images showing ultrasmall superpara-
magnetic iron oxide (USPIO)-labeled (A and
C) and unlabeled (B and D) macrophage sam-
ples in vitro. Cell concentrations were as fol-
lows: (A and B), 2.0 3 106 cells/mL and (C
and D), 0.5 3 106 cells/mL. Bulk samples for
these high-resolution MRI studies were pre-
pared in 1 mL plastic syringes by suspending
labeled or unlabeled macrophages in 5% gela-
tin. The dark spots in A and C appear to
represent single USPIO-labeled macrophages.
The slow varying shadow seen in (B and D)
are believed to be due to bulk field inhomoge-
neity brought about by imperfect shimming of
the magnet.
formaldehyde and embedded in paraffin and then were and ED1) based on the avidin-biotin-peroxidase com-
plex (ABC) method [26]. Sections were counterstainedlongitudinally cut into sections of 5 mm thickness. Sec-
tions from such samples were stained with hematoxylin with Mayer’s hematoxylin before permanent mounting.
Control sections were incubated with the same solutionand eosin (HE) and Perl’s Prussian blue (for visualizing
iron particles), respectively. One piece of fresh samples without primary antibodies. Cellular infiltration in the
renal cortex and medulla of each rat was expressed asfrom each animal was fixed in 2% glutaraldehyde buf-
fered with PBS for TEM studies. the number of cells per field of view (c/FV) at a magnifi-
cation of 3400; at least 10 fields of view were evaluatedSections from the third piece were snap frozen in OCT
(Tissue-Tek; Miles Inc., Elkhart, IN, USA) in cryomolds for each section.
and embedding rings and were stored under liquid nitro-
Statistical analysisgen. Cryostat sections were cut at 2228C and thaw
The data were expressed as mean 6 SD. The Student’smounted on glass slides. The sections were air dried,
t-test was used for comparison of results between twofixed in cold acetone, and stained individually with an
groups. For comparisons involving more than two groups,appropriate dilution of primary mouse anti-rat mono-
analysis of variance and the Student–Newman–Kuels testclonal antibodies against CD4 (T-helper cells), CD8 (cy-
were applied. P values # 0.05 were considered significant.totoxic T cells), and ED1 (macrophages) in PBS, pH
7.4, with 1% bovine serum albumin for one hour in a
humidified chamber. ED1 (Serotec, Raleigh, NC, USA)
RESULTS
recognizes a CD68-like antigen in most cells of the mono-
In vitro MR and TEM studies of USPIO particlescyte/macrophage system, while CD4 and CD8 (Serotec)
in macrophagesrecognize T-cell surface antigens. The sections were then
interacted with rabbit anti-mouse IgG by 3-amino-9- Gradient-echo MR images of USPIO-labeled and -un-
labeled macrophages in 5% gelatin are shown in Figure 1.ethylcarbazole (AEC; red color in CD8) or by peroxi-
dase-rabbit antiperoxidase (PAP; brown color in CD4 Figure 1 A and B show USPIO-labeled and -unlabeled
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Fig. 2. Gradient-echo MR images showing the effect of USPIO infusion. (A–C) Images from an isograft study immediately before (A) and
immediately after (B) USPIO infusion at POD 4, as well as one day following USPIO infusion (C) at POD 5. Images in (D–F) are from an
allograft experiment with a triple immunosuppressant treatment at corresponding time points and (G–I) are from an allograft study without
immunosuppressant treatment. In these panels, the transplanted kidneys appear on the right, and the native kidneys appear on the left. The
allograft study without the immunosuppressant treatment (I) shows a decrease of the MR signal intensity within the transplant at one day after
USPIO infusion. This decrease in MR signal intensity is believed to be due to an accumulation of macrophages containing USPIO particles in the
rejecting transplanted kidney.
samples, respectively, with a concentration of 2 3 106 of the figures, with native kidneys on the left side. MR
images are shown from an isograft study immediatelymacrophages/mL. Figure 1 C and D show USPIO-labeled
and -unlabeled samples, respectively, with a concentra- before (Fig. 1A), and immediately after (Fig. 1B) USPIO
infusion at POD 4, and one day after USPIO infusiontion of 0.5 3 106 macrophages/mL. Based on our USPIO-
labeled T-cell results [14], we believe that each dark spot (Fig. 1C). Images at corresponding time points are shown
in the labeled samples (Fig. 1 A, C) represents a single in Figure 2 D–F for allogeneic transplanted rats treated
USPIO-labeled macrophage. The density of these dark with immunosuppressants and in Figure 2 G–I for allo-
spots appears to be dependent on the concentration of grafts without immunosuppressant treatment. The allo-
macrophages. Measurements by TEM revealed that the graft without immunosuppressant treatment clearly
labeling efficiency of macrophages by USPIO particles shows an effect in the transplanted kidney at one day
in vitro is approximately 80%. This is much higher than following USPIO infusion, that is, an almost complete
the labeling efficiency previously measured for T cells darkening of the inner medulla and substantial signal
(20%) [14]. The labeling efficiency of USPIO particles decreases in the cortex and outer medulla (Fig. 2I). This
for both macrophages and T cells in vivo is not assessed MR signal reduction is believed to be due to the presence
in this study. of USPIO particles in macrophages present in the re-
jecting kidney. Immediately after the infusion, some
In vivo MRI studies of renal transplantation darkening can be seen in both native and transplanted
kidneys of most samples studied because of the presenceThe effect of USPIO particle infusion at POD 4 on
MRI of transplanted kidneys is shown in Figure 2 for of the USPIO particles in the vasculature.
Table 1 summarizes the MR signal intensity reductionsingle studies within each of the three experimental
groups: isograft; allograft with a triple immunosuppres- from five groups of renal transplanted rats, that is, iso-
graft group at POD 5 (N 5 5), allograft group with asant treatment; and allograft without immunosuppres-
sants. The transplanted kidneys appear on the right side triple immunosuppressive treatment at POD 5 (N 5 5),
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Table 1. Magnetic resonance imaging (MRI) signal intensity infiltration in the interstitium, particularly in or around
reduction of transplanted kidneys
glomeruli, and in vessels and perivascular areas (intimal
% change of MRI arteritis), and foci of severe tubulitis [28]. By POD 7,
signal intensity vessel walls were disrupted, and tubular cells were be-
Group Cortex Medulla coming edematous and necrotic. Both allografts with a
Isograft (N 5 5), POD 5 23.7610.4 21.664.5 triple immunosuppressive treatment and isografts showed
Allograft treated with minimal histologic changes at five days post-transplanta-
immunosuppressants (N 5 5), POD 5 21.9615.3 0.869.3
tion, with no apparent changes in the gross appearanceAllografta (N 5 11), POD 5 44.4633.5 39.1637.3
Allograftb (N 5 3), POD 3 26.262.8 218.3631.9 compared with that of native kidneys (results not shown).
Allograftb (N 5 3), POD 7 28.6619.8 225.9644.9
Data are mean 6 SD. Negative values represent an increase in the MRI signal Immunohistochemistry
intensity following infusion of USPIO particles. Details are in the text.
Stained cryosections of allograft kidneys without im-a Allografts without immunosuppressive treatment at postoperative day (POD)
5 showed significant change (P , 0.05) before and 24 hours after infusion of munosuppressive treatment at POD 5 are shown in Fig-
USPIO particles (results not shown)
ure 3. CD41 and CD81 T cells have extensively infil-b One study each for the POD 3 and POD 7 groups showed low MR signal
within the transplanted kidney before infusion of USPIO particles trated the glomerular capillary lumina, accompanied by
swelling of endothelial cells in the perivascular region
and interstitium. A large quantity of CD41 and CD81
T cells has infiltrated both the cortex (Fig. 3 A, C) andand allograft groups without immunosuppressive treat-
the medulla (Fig. 3 B, D). There are densely infiltratedment at POD 3 (N 5 3), POD 5 (N 5 11), and POD 7
areas of CD41 and CD81 T cells in each section, mostly(N 5 3). The negative values in Table 1 represent an
surrounding the vessels and glomeruli or tubules of theincrease in MRI signal intensity following infusion of
medulla. ED1 staining shows that a large resident popu-USPIO particles. Only the allograft group without immu-
lation of ED11 macrophages is present in the tubulo-nosuppressive treatment at POD 5 exhibited substantial
interstitium and around or in the glomeruli of allograftMR signal intensity reduction in both the cortex and
kidneys without immunosuppressive treatment (Fig. 3
medulla. In the allograft group without immunosuppres-
E, F). The infiltration became more prominent as the
sive treatment at POD 5, MR signal intensity did not de- severity of kidney rejection increased during the acute
crease in the cortex nor in the medulla in three studies nor rejection process. Very few ED11 macrophages and
in the medulla in two studies, resulting in a high standard CD41 and CD81 T cells were found in isografts, allo-
deviation (SD) of that group. Only in the case of allograft grafts with immunosuppressive treatment, or native kid-
group without immunosuppressive treatment was there neys (results not shown).
a significant difference (P , 0.05) between pre- and Macrophages and T cells of both cortex and medulla
postinfusion of USPIO means (results not shown). One were detected immunochemically in cryostat sections in
syngeneic sample that showed abdominal duct leakage each allograft without immunosuppressive treatment.
leading to severe infection and one allogeneic sample Graphs of the quantitative results are shown in Figure 4.
without immunosuppressive treatment that showed se- At days 3 and 5 post-transplantation, CD41 and CD81
vere peritonitis caused by abdominal lymphatic duct populations and ED1 monocytes/macrophages increased;
leakage were excluded from numerical analysis in Table this increase reached very substantial levels at POD 5,
1; these two studies showed a reduction of MR signal decreasing thereafter (Fig. 4).
intensity in both transplanted and native kidneys. Table 2 summarizes our immunohistologic results at
POD 5 of kidney allografts, allografts with a triple immu-
Histological studies nosuppressive treatment, and isografts. Immune cell in-
The blood chemistry showed that there was no signifi- filtration was dramatic in the allograft group without
cant increase of serum creatinine levels in any of the immunosuppressive treatment at five days post-trans-
groups studied (results not shown). The low creatinine plantation. Only mild immune cell infiltration occurred
levels are attributable to the existence of the contralat- in the allograft group with immunosuppressive treatment,
eral native kidney [27]. while minimal infiltration was observed in the isograft
In allografts without immunosuppression, several his- group.
tologic changes were noted at POD 3 after engraftment, There was dense staining of CD41 and CD81 T cells
that is, a mild epithelial edema of tubules and a mild aggregated in adjacent arteries (white pulp) in the spleen
interstitial mononuclear cell infiltration. By POD 5, the of allograft animals (results not shown). In contrast,
allograft kidneys were enlarged, and the presence of there was minimal dense staining of ED11 macrophages
acute rejection was confirmed. These morphological in the parenchyma (red pulp) of the spleen (results not
changes are characteristic of acute rejection of type A, shown). The discrepancy between T-cell and macro-
phage locations may reflect the activity of recruit-acti-namely a significant increase of host mononuclear cell
Zhang et al: MRI detects immune cells in rejecting kidney1306
Fig. 5. Optical microscopy of graft kidneys stained with Perl’s Prussian
blue at POD 5: Allograft kidneys without immunosuppressive treatment
(A–D) and isograft kidneys (E ) and (F ). (A, C, and E) Cortex and (B,
D, F) medulla. There were large numbers of dense core plaques in
(A) surrounding the glomeruli or renal tubular structure. Amorphous
plaques and empty cores were found in the perivascular, renal encapsu-
late distribution (C) and in the blood vessels (D) of allograft kidneys.
No iron plaques were found in either cortex (E) or medulla (F) of
isograft kidneys. Magnification 3200.
Fig. 3. Optical microscopy showing immunohistochemical detection of
CD41 and CD81 T-cell and ED11 macrophage infiltration at post-
operative day (POD) 5 in allograft kidneys without immunosuppressive
treatment. Cryosections were stained with monoclonal antibodies to
CD4 and CD8 T cells and ED1 macrophages, and then the sections concentrations of iron, were present in 7 out of 10 allo-
were reacted with rabbit or goat anti-mouse IgG by AEC (red color
graft recipients. A high concentration of iron-containingin CD8) or by PAP (brown color in CD4 and ED1). (A and B) CD41
T cells. (C and D) CD81 T cells. (E and F) ED11 macrophages. (A, C, macrophages was also identified in spleen parenchyma
and E) are cortex and (B, D, and F) are medulla. Magnification 3400. of all groups at three, five, and seven PODs in this study.
The iron plaques in macrophages could be categorized
as one of three types: dense core plaques (Fig. 5A), diffuse
amorphous plaques (Fig. 5 C, D), or empty core plaquesvated macrophages in spleen, which are responsible for
(Fig. 5 C, D). The dense core plaques often had a halothe intake and destruction of particulate antigens.
of stain surrounding them with an unstained area between
Iron staining for USPIO detection the dense core and the halo. Sometimes, there were sev-
eral dense core plaques surrounding the nucleus in oneAfter staining with Perl’s Prussian blue, iron deposits
macrophage. Small, dense iron plaques distributed mostlywere observed in macrophages both in the cortex (around
in the cortex (near vessels or in glomeruli; Fig. 5A).glomeruli, tubules, and vessels) and the medulla (in inter-
Amorphous plaques were consistently stained through-stitium) at POD 5 in allografts without immunosuppres-
out their width; these plaques were often distributedsive treatment (Fig. 5 A–D). In each sample of this group,
near or in blood vessels in an allograft kidney. The emptyiron was visibly stained in the outer medulla adjacent
to the cortex. Round macrophages, typically with high core plaques had a center that was unstained. In isograft
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kidneys, Prussian blue staining was not observed in the
cortex (Fig. 5E) or in the medulla (Fig. 5F), nor were
iron plaques observed in native kidneys or in allograft
kidneys with immunosuppressive treatment. The distri-
bution of iron plaques as seen by Perl’s Prussian blue
staining was well correlated with the distribution of
ED11 macrophages in allograft kidneys without immu-
nosuppressive treatment at POD 5 (results not shown).
However, there was no observable evidence of iron parti-
cles in the T cells of the allograft kidneys without immu-
nosuppressive treatment, presumably because of the
much smaller number of T cells containing USPIO parti-
cles. Our previous results indicated that about 20% of
T cells took up USPIO particles under cell culture condi-
tions [14], whereas about 80% of macrophages ingested
the USPIO particles in the present study.
Ultrastructure of the USPIO-lysosomes contained in
the kidney
Figure 6 shows TEM detection of iron particles within
the lysosomes of a macrophage from an allograft kidney.
A number of granules composed of iron particles were
observed in lysosomes. Many granules form one vacuole
unit, which we believe to be the plaque seen in optical
microscopy after Prussian blue staining. No free iron
particles were observed in the tubular cells and intersti-
tium. There was no evidence of iron particles in either the
native kidneys, isograft kidneys, or the allograft kidneys
with triple immunosuppressive treatment. There were
numerous dense iron vacuoles contained in the macro-
phages of the spleen in each animal.
DISCUSSION
The most important finding of this work is that intrave-
nous infusion of USPIO particles caused a significant
decrease in the MR signal intensity of allogeneic trans-
planted kidneys in rats compared with those of control
nontransplanted kidneys. Immediately after a bolus in-
jection of USPIO particles containing 4.5 mmol iron,
signal intensity reduction was usually detectable in MR
images in both native and transplanted kidneys and in
liver, spleen, and large blood vessels because of the pres-
ence of USPIO particles in the vascular system. At oneFig. 4. Quantitation of CD41 and CD81 T-cell and ED11 macrophage
infiltration in allograft kidneys without immunosuppressive treatment. day following USPIO infusion on POD 4, the MR signal
Cell counts were performed under an optical microscope at a magnifica- intensity of the native and isograft kidneys and allografttion of 3400 at POD 1 (N 5 5), POD 3 (N 5 3), POD 5 (N 5 11),
kidneys with a triple drug immunosuppressive treatmentand POD 7 (N 5 3). Minor offsets (,0.5 day) along the POD axis
between groups are for illustrative purposes only and do not represent was restored to the level of preinfusion. In contrast, after
a real shift in time. Data are expressed as mean 6 SE. Symbols are: transplantation of allograft kidneys without immunosup-(d) cortex; (j) medulla; *P , 0.05 by Student’s t-test for days 3, 5,
pressive treatment in our rat model (DABN), MRI signaland 7 versus day 1 for cortex and medulla. The abbreviation c/FV is
the number of cells per field of view. intensity of the transplanted kidney in the allograft group
was decreased one day following the initial infusion of
USPIO particles on POD 4 (Table 1). Our results have
confirmed that acute rejection can be effectively inhib-
ited in kidney allografts administered with a triple-drug
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Table 2. Immunohistology at postoperative day (POD) 5 of kidney allografts, allografts with a triple immunosuppressive treatment, and isografts
ED11 cells (c/FV) CD41 cells (c/FV) CD81 cells (c/FV)
Groups N Cortex Medulla Cortex Medulla Cortex Medulla
Allografts 11 84.869.1 106.7614.1 109.869.4 116.5610.7 80.4610.6 76.3615.2
Allograftsa 5 7.861.7b 9.661.1b 12.662.7b 14.362.1b 19.562.5b 20.862.5b
Isografts 6 0.360.5b 0.260.4b 1.260.9b 2.761.6b 0.260.4b 0.160.8b
a Allografts with a triple immunosuppressive treatment (see text for details)
b P , 0.001, allografts treated with triple immunosuppressive treatment vs. allografts, and isografts vs. allografts
Fig. 6. Transmission electron microscopy
(TEM) results showing ultrastructural mor-
phology of a macrophage in an allograft kid-
ney without immunosuppressive treatment at
POD 5. (A) USPIO particles were contained
within a vacuole (in square) in a macrophage
near the outer medulla, with several particles
accumulating within one vacuole. (B) The vac-
uole itself [expansion of area within square of
(A) was a lysosome containing many dense
granules of USPIO particles, arrow head].
Magnification 39400 in A; 370,700 in B.
immunosuppressive treatment [29]. This study shows a ate the functional changes of the kidney based on the
USPIO vascular kinetics in this early period. However,consistent progression of infiltration of ED11 macro-
phages and CD41 and CD81 T-cells that peaks at POD 5 USPIO particles in the normal vasculature are elimi-
nated quite slowly, as their half-life in the rat is aboutafter transplantation (Fig. 4), as well as MRI signal inten-
sity reduction (Table 1) in transplanted kidneys of the two hours [15, 17–20].
We postulate that the macrophages that infiltrate theallograft group without immunosuppressive treatment.
Prussian blue staining shows the existence of numerous allograft kidneys may have several different origins. One
major source probably is blood monocytes, since theiron plaques in the cortex and medulla of the untreated
allograft (Fig. 5). We attribute each plaque to a large renal vessels contain a large proportion of monocytes
saturated with USPIO particles. In the group of allograftvacuole phagocytosed by macrophages, which then infil-
trate the interstitium of the allograft kidney. The pres- recipients at 7 days post-transplantation and in some
cases at POD 5, the allograft kidneys experienced severeence of USPIO-containing vacuoles in macrophages is
believed to cause the decrease in the MR image intensity rejection and were greatly enlarged without MR signal
loss. It was shown in our recent study that the renalas shown in Figure 2I in the cortex and medulla of un-
treated allograft kidneys at POD 5. cortical perfusion rate in allogeneic transplanted kidneys
at the peak of acute rejection is greatly reduced com-A potential advantage of USPIO particles over macro-
molecular MRI contrast agents is that intracellular deg- pared with that in syngeneic kidneys [27]. The reduced
blood flow may be insufficient to supply enough bloodradation of USPIO particles occurs in tubular lysosomes
and iron degradation products are incorporated into the macrophages and lymphocytes carrying USPIO particles
to the graft, which could account for the substantiallynormal pathway. Prior studies have shown no cytotoxic
effect of USPIO in cell culture and in the human body lower reduction in MR signal intensity observed at those
time points. In our DA!BN rat model, severe acute[12, 13, 16–19, 30–32]. USPIO particles can act as an
MRI blood-pool contrast agent, which can be used to rejection begins around POD 5, but variations in the
initiation of rejection could occur. Although the role ofmark the vascular compartment within the first few hours
after infusion of USPIO particles. It is possible to evalu- local proliferation of immune cells in augmentation of
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